Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2000
04/18/2000US6051724 An antileukemia and antitumor agents
04/18/2000US6051722 Compounds, polymers, resin compositions and nonlinear optical devices
04/18/2000US6051712 Piperidine derivatives having renin inhibiting activity
04/18/2000US6051599 Endothelin receptor antagonists
04/18/2000US6051574 Anticancer agents
04/18/2000CA2194080C Novel process for preparing 2,6-di(4,6-dimethoxypyrimidin-2-yl) oxybenzoic acid oxime ester derivatives
04/16/2000CA2252144A1 Dual action anticancer prodrugs
04/13/2000WO2000020410A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof
04/13/2000WO2000020402A1 Chemical compounds
04/13/2000WO2000020399A2 Use of substituted 5-hydroxypyrazoles, novel 5-hydroxypyrazoles, methods for the production thereof and agents containing the same
04/13/2000WO2000020398A1 Biphenylene lactams as prostaglandin receptor ligands
04/13/2000WO2000020393A1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
04/13/2000WO2000020358A2 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
04/13/2000WO2000002877A3 New pharmaceutically active compounds
04/13/2000WO2000002850A3 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators
04/13/2000DE19845406A1 Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Substituted 1,3-diaryl-2-pyridin-2-yl-3- (pyridin-2-ylamino) - propanol derivatives, process for their preparation, pharmaceutical compositions containing them and their use
04/13/2000DE19845402A1 Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung -Containing heterocycles substituted with Propanolaminderivate, process for their production, medicaments containing these compounds and their use
04/13/2000CA2346445A1 Biphenylene lactams as prostaglandin receptor ligands
04/13/2000CA2346083A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof
04/13/2000CA2341374A1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases
04/13/2000CA2341346A1 Non-peptide gnrh agents, methods and intermediates for their preparation
04/12/2000EP0992492A1 Small molecule inhibitors of rotamase enzyme activity
04/12/2000EP0991753A1 Protease inhibitors
04/12/2000EP0991654A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
04/12/2000EP0991647A1 Eprosartan monohydrate
04/12/2000EP0991645A1 Bis-indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them
04/12/2000EP0991643A1 Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase
04/12/2000EP0991633A1 Novel heterocyclic compounds
04/12/2000EP0991624A1 Phenylalkyl derivatives with thrombin-inhibiting effect
04/12/2000EP0991623A2 Quinoline-indole antimicrobial agents, uses and compositions related thereto
04/12/2000EP0991621A1 Novel heterocyclic compounds
04/12/2000EP0759917B1 Novel selective inhibitors of viral or bacterial neuraminidases
04/12/2000CN1250447A 4-(3-heterocyclyl-1-benzoyl) pyrazoles and their use as herbicides
04/12/2000CN1250442A Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof
04/12/2000CN1250441A Pesticidal 1-arylpyrazoles
04/12/2000CN1250440A Process for preparing pyrazole derivatives
04/12/2000CN1051315C Phosphonooxymethyl ethers of taxane derivatives
04/12/2000CN1051310C Furyl or thienyl carbonyl substituted taxanes and pharmaceutical composition containing same
04/12/2000CN1051309C Fluoro taxols
04/11/2000US6048880 Therapy for cytokine sensitive diseases
04/11/2000US6048875 Benzothiophene, benzofuran and indole compounds
04/11/2000CA2129995C Piperidinyl thiacyclic derivatives
04/11/2000CA2082617C Mesomorphic compound, liquid crystal composition, liquid crystal device, display apparatus and display method
04/06/2000WO2000018764A1 Benzimidazolinyl piperidines as cgrp ligands
04/06/2000WO2000018761A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
04/06/2000WO2000018759A1 Phenylalanine derivatives as alpha 4 integrin inhibitors
04/06/2000WO2000018758A1 Pyrimidone derivatives
04/06/2000WO2000018753A1 2-phenylpyran-4-one derivatives
04/06/2000WO2000018749A1 Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
04/06/2000WO2000018742A1 Sulfonyltriazol derivatives and their use for combating micro-organisms
04/06/2000WO2000018740A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
04/06/2000WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors
04/06/2000WO2000018723A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/06/2000WO2000018361A2 Method of treating hair loss using sulfonamides
04/06/2000WO2000018231A1 Methods for treating or preventing viral infections and associated diseases
04/06/2000WO1999061013A3 COMPOUNDS HAVING IgE AFFECTING PROPERTIES
04/06/2000CA2345359A1 Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
04/06/2000CA2345357A1 Benzimidazolinyl piperidines as cgrp ligands
04/06/2000CA2345347A1 Methods for treating or preventing viral infections and associated diseases
04/06/2000CA2345108A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/06/2000CA2345065A1 Pyrimidone derivatives
04/06/2000CA2340454A1 Benzamide derivatives and their use as cytokine derivatives
04/06/2000CA2338442A1 Phenylalanine derivatives as alpha 4 integrin inhibitors
04/05/2000EP0740791A4 Systematic modular production of aminimide- and oxazolone-based molecules having selected properties
04/05/2000CN1249751A Substd. 2,4-diaminopyrimidines
04/05/2000CN1249749A Phthalazinones
04/05/2000CN1249748A Small molecules useful in treatment of inflamatory disease
04/05/2000CN1249743A Arylsulfonylamino hydroxamic acid derivs
04/05/2000CN1249742A Anti-inflammatory compounds
04/05/2000CN1249682A Use of angiotension II antagonists to treat symptomatic heart failure
04/04/2000US6046355 Dihydropyrones with improved antiviral activity
04/04/2000US6046227 Useful in the treatment of type ii diabetes and obesity; a substituted pyrazine compound
04/04/2000US6046218 Pyridine derivative and medicament containing the same as an effective ingredient
04/04/2000US6046215 A piperidinylbenzothiophenes useful for trating brain disorders
04/04/2000US6046210 Antipsychotic agents
04/04/2000US6046191 Combination
04/04/2000US6045398 Battery accepting unit and battery pack
04/04/2000CA1340949C Imidazole compounds and biocidal composition comprising the same for controlling harmful organisms
03/2000
03/30/2000WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000WO2000017184A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
03/30/2000WO2000017166A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors
03/30/2000WO2000017164A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
03/30/2000WO2000017162A1 Novel thiol derivatives, process for producing the same and utilization thereof
03/30/2000WO2000017158A1 Urokinase inhibitors
03/30/2000WO2000016603A2 Bridged heterocyclic derivatives
03/30/2000DE19844547A1 Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Polycyclic Dihydrothiazole, processes for their preparation and their use as medicaments
03/30/2000DE19844497A1 Sulfonyltriazol-Derivate Sulfonyltriazol derivatives
03/30/2000CA2345311A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
03/30/2000CA2344556A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
03/30/2000CA2344412A1 Thiol compound, their production and use
03/30/2000CA2344376A1 Bridged heterocyclic derivatives
03/30/2000CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/29/2000EP0988301A1 Imidazolyl-cyclic acetals
03/29/2000EP0988299A1 Polymerisable, optically active dioxolane diesters
03/29/2000EP0988298A1 Coumarin derivatives, methods of preparation and application as medicines
03/29/2000EP0988292A2 Piperazine derivatives and their use as anti-inflammatory agents
03/29/2000EP0739343B1 Water soluble onium salt of taxo-diterpenoid
03/29/2000CN1248968A Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCRI receptor